Announcements

We’re proud to announce our DMF (Drug Master File) approval

May 14, 2025

We’re proud to announce our DMF (Drug Master File) approval and successful commercial launch in the US market. This marks a significant step forward in our commitment to global healthcare excellence.

Approved DMF’s in US

Respiratory

Azelastine HCL

Budesonide

Ciclesonide

Fluticasone Furoate

Fluticasone Propionate

Formoterol Fumarate Dihydrate

Mometasone Furoate Anhydrous

Mometasone Furoate Monohydrate

Triamcinolone Acetonide

Anti-Inflammatory

Triamcinolone Hexacetonide

Under review DMF’s in US

Deflazacort

DMF’s Filed in US

Exemestane